Cyclo Therapeutics IncEigentümerstruktur
| Preis (2017-12-01) | 52W Hoch | 52W Tief |
| 9900 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 0,95 USD | 1 | 0 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 32.736.300 | 1,51 | 5,58 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Cyclo Therapeutics Inc
Mitarbeiter 8
Handelsplatz NASDAQ
Ticker Symbol CYTH
IPO Datum 2011-02-23
Adresse 6714 NW 16th Street, Gainesville, FL, United States, 32653
Webseite https://cyclotherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. N. Scott Fine | CEO & Director |
| 2 | Mr. C. E Strattan | Founder & Director |
| 3 | Mr. Joshua M. Fine | CFO & Secretary |
| 4 | Mr. Michael Eric Lisjak | Senior VP of Business Development & Chief Regulatory Officer |
| 5 | Dr. Jeffrey L. Tate Ph.D. | COO, Chief Quality Officer & Director |
| 6 | Ms. Lori McKenna | Global Head of Patient Advocacy |
| 7 | Dr. Karen Mullen FFPM | Interim Chief Medical Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | SBI Securities Co Ltd | 0,00% | 0,00 Mio. USD |